Research uses plant breeding and biotechnology to remove proteins associated with food allergies.
An immunotherapy agent combined with a tyrosine kinase inhibitor drug whose clinical testing as a first-line treatment in advanced kidney cancer was led by Toni K. Choueiri, MD, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, has become a standard therapy.
Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic
Credentialed press representatives are invited to attend The Society of Thoracic Surgeons VIRTUAL 57th Annual Meeting. This interactive, fully digital experience—expected to be unlike anything that cardiothoracic surgery has experienced to date—will feature thought-provoking lectures, practice-changing science, and cutting-edge techniques and technologies.
Human error is a causal factor in up to 80 percent of workplace accidents. A new study measuring the eye movements and cognitive processes for at-risk workers, sheds new light on the potential to avert accidents and possibly prevent workplace injuries. The study “Measuring attention, working memory, and visual perception to reduce risk of injuries in the construction industry,” by Behzad Esmaeili, Ph.D., George Mason University challenges the conventional, reactionary paradigm of safety-risk management.
The pandemic has impacted farmers, children, plant workers and even office workers in unique ways that go beyond physical illness. Several studies that explore these individualized effects will be presented during the Individual Impacts of Global Pandemic Risks session and the COVID-19: Risk Communication and Social Dynamics of Transmission and Vulnerability symposia, both from 2:30-4:00 p.m. ET on December 15, at the 2020 Society for Risk Analysis virtual Annual Meeting, December 13-17, 2020.
Several studies that aim to characterize and quantify the release and composition, particle size, and residence time in the indoor environment will be presented in the Exposure and Risk Assessment of 3D Printing and Emerging Materials symposium on December 15, from 12:00-1:30 p.m. ET at the 2020 Society for Risk Analysis virtual Annual Meeting held December 13-17, 2020.
DALLAS – Dec. 14, 2020 – Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.
At the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, a series of late-breaking sessions will delve into the newest research on the rapidly evolving COVID-19 pandemic. Highlights of these sessions include a talk that will provide expert insight into the many coronavirus vaccines currently in development, as well as an expert presentation on coronavirus immunity and antibody testing.
A new study shows that a first-of-its-kind rapid test could identify which COVID-19 patients are responding to drug treatments and which patients are still deteriorating and need higher doses of medication. Findings on this method and on a second test that could predict COVID-19 severity were presented today at the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo.
AACC is pleased to announce the recipients of the AACC 2020 Top Corporate Supporter Awards. This year, AACC recognizes 45 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
The opioid epidemic has only gotten worse since the advent of COVID-19, with some areas in the U.S. reporting a 50% increase in drug overdoses due to the pandemic. With no end in sight to this public health crisis, scientific sessions during the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will highlight the integral role of clinical laboratories in efforts to manage it, as well as the latest drug tests needed to do so.
During the all-virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, leading scientific experts will dive into the groundbreaking advances that are the future of cancer care. One plenary session will focus on the cutting-edge treatment known as T cell therapy, while another will showcase recent discoveries about tumor metabolism that could lead to new, more effective cancer drugs.
Artificial intelligence (AI) has the potential to revolutionize healthcare, but integrating AI-based techniques into routine medical practice has proven to be a significant challenge. A plenary session at the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will explore how one clinical lab overcame this challenge to implement a machine learning-based test, while a second session will take a big picture look at what machine learning is and how it could transform medicine.
In the wake of the novel coronavirus pandemic, the need for reliable, accurate, and accessible laboratory testing is more evident than ever before. At the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care for COVID-19 and across the spectrum of healthcare.
Researchers have developed a method using ultrasound imaging to score a patient’s lung health, which may help predict if a patient with COVID-19 will worsen. Using 14 points in the lungs, they looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, the researchers found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Umberto Sabatini’s presentation will be a part of the 179th ASA Meeting of the Acoustical Society of America.
Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients’ ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women’s Cancer Center investigators shows.
Physicians did not recognize side effects from radiation therapy in more than half of breast cancer patients who reported a significant symptom, a new study finds.
Baebies has been named a finalist for the 2020 American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award for FINDER®, a near-patient testing platform. As a growth-stage company developing diagnostic products to provide a healthy start for children everywhere, Baebies FINDER tests for diseases from low blood volume (50 µL) with a turn-around time of approximately 15 minutes after sample introduction.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right